Xavier Paolettí
Inserm(FR)Inserm(FR)Université Paris Sciences et Lettres(FR)Université Paris-Saclay(FR)Centre de recherche en Epidémiologie et Santé des Populations(FR)Centre Oscar Lambret(FR)Institut Curie(FR)Institut Curie(FR)
Publications by Year
Research Areas
Statistical Methods in Clinical Trials, Cancer Genomics and Diagnostics, Health Systems, Economic Evaluations, Quality of Life, Ovarian cancer diagnosis and treatment, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial(2015)1,100 cited
- → Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma(2017)598 cited
- → EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype(2014)381 cited
- → Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program)(2012)275 cited
- → Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis(2013)172 cited
- → Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)